Skip to content

Impact of Patient Position on Chemical Pleurodesis by Chest Ultrasound

Impact of Patient Position on Chemical Pleurodesis by Chest Ultrasound

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07147270
Enrollment
30
Registered
2025-08-29
Start date
2025-05-01
Completion date
2026-02-28
Last updated
2025-08-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Effect of Patient Rotation on Pleurodesis Success and Patient Comfort, Malignant Pleural Effusion, Pleurodesis

Brief summary

chemical pleurodesis using doxycycline is an acceptable and commonly employed palliation for malignant pleural effusion. Rotation of patient during pleurodesis using the powder from doxycycline capsule is still practiced in some centers. The benefit of rotation practice in pleurodesis can be verified after properly designed study on the outcome of pleurodesis with rotation and non-rotation by chest ultrasound assessment

Detailed description

Pleurodesis through thoracoscopy could be done if the pleura appears abnormal on direct inspection thus offers diagnostic and therapeutic procedures in a single sitting. Talc is considered the best known sclerosing agent especially when used by medical thoracoscopy/pleuroscopy (MT/P). Unfortunately, a serious complication can occur with its use. Graded talc,which is the safest form is not available in many developing countries, including Egypt. Also, injectable tetracyclines' synthesis has been ceased worldwide. Meanwhile, the oral forms of doxycycline are readily available, inexpensive and as effective as its parenteral forms in inducing pleurodesis. Therefore it will be used, aiming to assess the efficacy, safety and outcome of pleurodesis with and without patient rotation using doxycycline in malignant pleural effusion. Rotation of patients during tetracycline pleurodesis has been a common practice even at the moment. However, it had been proven that intrapleural instillation of parental tetracycline, a water soluble substance, to achieve chemical pleurodesis does not require rotation of patients as the tetracycline is distributed completely throughout the pleural space within seconds, and the distribution is not enhanced by patient's rotation.

Interventions

OTHERside to side and front to back rotation 30 minutes each

side to side and front to back rotation 30 minutes each after pleurodesis

Sponsors

Ain Shams University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Patients who will be admitted at Chest department, Ain-Shams University Hospitals with malignant pleural effusions candidate for pleurodesis

Exclusion criteria

* Multiloculated fluid * Previous failed pleurodesis * Liver failure * Renal failure * Congestive heart failure * Prolonged use of steroids or NSAIDs * Refusal to participate

Design outcomes

Primary

MeasureTime frameDescription
Measurement of pleural adhesion score in patients with malignant pleural effusion candidates for pleurodesis in group with rotation and the other without rotationimmediatly and after one month from pleurodesisstudy how patient rotation after pleurodesis affects its success by measuring pleural adherence score by chest ultrasound, a higher adhesion score means successful pleurodesis

Secondary

MeasureTime frameDescription
Measurement of non-verbal Pain score in patients with malignant pleural effusion candidates for pleurodesis in group with rotation and the other without rotationimmediately after pleurodesisEstimation of non-verbal pain score in patients with and without rotation after pleurodesis to assess how this rotation affects patients' comfort. A higher pain score means less comfort.

Countries

Egypt

Contacts

Primary ContactHieba G Ezzelregal, MD
hiebagamal24@med.asu.edu.eg01002041611
Backup ContactAhmed M Abdelsamad
01008662384

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 1, 2026